The company will provide comprehensive response to USFDA for the observations
The company has received five final approvals
Prior to joining Alembic, he was working with Lupin Limited for more than 11 years
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
Alembic has reported total income of Rs. 39.15 crores during the period ended March 31, 2023
The company has reported total income of Rs. 1407.34 crores during the period ended March 31, 2023
Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Subscribe To Our Newsletter & Stay Updated